30%
40%
50%
60%
C. 50%
epirubicin
mitomycin c
BCG
none of the above
mid prostate to the verumontanum at the 5 and 7 oclock positions
lateral margins of the prostate at the 10 and 2 oclock positions
entire area distal to the urethral crest
area between ejaculatory duct openings and prostatic utricle
only in females
associated with chronic irritation, polypoid cystitis, and cystitis glandularis
no risk for squamous cell carcinoma
treated with estrogen, if symptomatic
never
unlikely
likely
always
often of high-grade sarcomas
often associated with muscularis propria invasion
due to vesical polyps occluding ureteric orifices
should be resected but not diathermized
working with organic chemicals and dyes
abuse of pain-control medications especially phenacetin
exposure to arsenic and aromatic amines
schistosomiasis
immediately before operation
immediately before incision and post-operative for 1 day
immediately before incision and post-operative for 15 days
immediately before incision and post-operative for 30 days
history of pulmonary TB
total incontinence
immunosuppression
impaired renal function
40 - 55%
55 - 70%
70 - 85%
85 - 100%
the standard treatment is transurethral resection
the prognosis for inverted papilloma is pathetic, with a recurrence rate of approximately 65%
the likelihood of synchronous urothelial carcinoma is 26%
has been shown to harbor p53 gene mutations
RB
cyclin A
HRAS
CD-44
urine cytology
CT urography
cystoscopy
renal function tests
there will be no target tumor tissue to work on
post-op. hematuria interacts unfavorably with BCG composition
of the risk of systemic absorption and sepsis
of the high risk of BCG reflux to kidneys while bladder irrigation
adenocarcinoma
transitional cell carcinoma
squamous cell carcinoma
comparable
radical cysto-prostatectomy
anterior pelvic exenteration
bilateral pelvic lymphadenectomy
creation of a urinary diversion
increase the irrigation fluid and pursue the procedure
abort the procedure and leave a urethral catheter
perform cystogram and manage accordingly
perform abdominal exploration and manage accordingly
0.6 - 2%
2 - 6%
6 - 10%
12 - 16%
patients with carcinoma in situ
patients with completely resected solitary tumor
patients with preserved kidney and liver functions after 2 courses of BCG
patients with leiomyosarcoma
rarely diagnosed at autopsy
the peak incidence occurs between ages 70 and 80
they occur twice as frequently in men as in women
none of the above
nodular or sessile lesions usually invade muscle
papillary bladder tumors are typical of low stage and grade
carcinoma in situ appears as a flat, velvety patch
sarcomas commonly invade bladder base and ureteral orifices causing obstructions
transitional cell carcinoma
squamous cell carcinoma
adenocarcinoma
small cell carcinoma
sensitivity to chemotherapy and age at presentation
anatomic location and extent of the tumor
histologic type of the tumor and sensitivity to radiotherapy
tumors stage and grade
multifocality
high tumor grade and advanced stage
presence of CIS
all of the above
adenocarcinoma
transitional cell carcinoma
squamous cell carcinoma
basal cell carcinoma
2 - 4%
4 - 6%
6 - 8%
8 - 10%
ascending urethrography
voiding cystourethrography
MRI
IVU
high specificity
high sensitivity
high reliability
strong validity
single intravesical chemotherapy
TURBT
intravesical BCG vaccine
multiple bladder biopsies
frequently found in association with high-grade or extensive TCC
has a rate of progression to muscle invasion of 10-25%
significant areas of CIS are easily missed by routine cystoscopy
treatment begins with TURBT
30%
40%
50%
60%